Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eleven ratings firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $8.00.

A number of research firms have weighed in on HCAT. Evercore ISI lowered shares of Health Catalyst from an "outperform" rating to an "inline" rating in a research report on Wednesday, April 9th. Citigroup cut their target price on shares of Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Friday, April 25th. KeyCorp cut their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Stifel Nicolaus upped their price objective on shares of Health Catalyst from $5.00 to $5.50 and gave the company a "hold" rating in a research report on Thursday, May 8th. Finally, BTIG Research lowered shares of Health Catalyst from a "buy" rating to a "neutral" rating in a research report on Tuesday, June 17th.

Health Catalyst Stock Down 2.7%

Health Catalyst stock opened at $3.95 on Tuesday. The firm has a market cap of $274.92 million, a price-to-earnings ratio of -3.43 and a beta of 1.51. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.24 and a quick ratio of 1.24. Health Catalyst has a fifty-two week low of $3.49 and a fifty-two week high of $9.24. The firm has a fifty day moving average price of $3.93 and a two-hundred day moving average price of $4.72.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HCAT. SG Americas Securities LLC increased its holdings in shares of Health Catalyst by 195.2% during the first quarter. SG Americas Securities LLC now owns 80,825 shares of the company's stock worth $366,000 after buying an additional 53,443 shares in the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Health Catalyst during the fourth quarter worth approximately $735,000. Wells Fargo & Company MN increased its holdings in shares of Health Catalyst by 27.3% during the fourth quarter. Wells Fargo & Company MN now owns 39,355 shares of the company's stock worth $278,000 after buying an additional 8,451 shares in the last quarter. Two Sigma Investments LP acquired a new stake in shares of Health Catalyst during the fourth quarter worth approximately $496,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Health Catalyst during the fourth quarter worth approximately $2,044,000. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.